Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey

Kilickap, S.Ozturk, A.Karadurmus, N.Korkmaz, T.Yumuk, P.Cicin, I.Paydas, S.2024-04-242024-04-2420181556-08641556-1380https://hdl.handle.net/11468/23191[Abstract Not Available]eninfo:eu-repo/semantics/closedAccessNsclcAlk InhibitorCrizotinibCrizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from TurkeyCrizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from TurkeyConference Object1310S477S478WOS:000454014501235Q1